Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-10-16

Clinical Trial Update: Effect of Androgen Suppression on Bone Loss in Patients With or Without Bone Metastases Secondary to Prostate Cancer [NA]

View source ↗

Summary

This clinical trial update notes the completion of a study evaluating the impact of androgen suppression on bone loss in men with prostate cancer, with and with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Rochester | Conditions: Osteoporosis, Prostate Cancer | NA | Status: COMPLETED